These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21055618)

  • 1. Multivalent cyclic RGD ligands: influence of linker lengths on receptor binding.
    Kubas H; Schäfer M; Bauder-Wüst U; Eder M; Oltmanns D; Haberkorn U; Mier W; Eisenhut M
    Nucl Med Biol; 2010 Nov; 37(8):885-91. PubMed ID: 21055618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
    Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
    J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionalized cyclic RGD peptidomimetics: conjugable ligands for αvβ3 receptor imaging.
    Arosio D; Manzoni L; Araldi EM; Caprini A; Monferini E; Scolastico C
    Bioconjug Chem; 2009 Aug; 20(8):1611-7. PubMed ID: 21141806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic RGD-polyethylene glycol-polyethylenimine for intracranial glioblastoma-targeted gene delivery.
    Zhan C; Meng Q; Li Q; Feng L; Zhu J; Lu W
    Chem Asian J; 2012 Jan; 7(1):91-6. PubMed ID: 22072592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimerization of cRGD peptides by click chemistry: synthetic strategies, chemical limitations, and influence on biological properties.
    Wängler C; Maschauer S; Prante O; Schäfer M; Schirrmacher R; Bartenstein P; Eisenhut M; Wängler B
    Chembiochem; 2010 Oct; 11(15):2168-81. PubMed ID: 20827791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RGD modified albumin nanospheres for tumour vasculature targeting.
    Dubey PK; Singodia D; Verma RK; Vyas SP
    J Pharm Pharmacol; 2011 Jan; 63(1):33-40. PubMed ID: 21155813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific detection of integrin αvβ3 by light-up bioprobe with aggregation-induced emission characteristics.
    Shi H; Liu J; Geng J; Tang BZ; Liu B
    J Am Chem Soc; 2012 Jun; 134(23):9569-72. PubMed ID: 22642547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic RGD peptide-conjugated polyplex micelles as a targetable gene delivery system directed to cells possessing alphavbeta3 and alphavbeta5 integrins.
    Oba M; Fukushima S; Kanayama N; Aoyagi K; Nishiyama N; Koyama H; Kataoka K
    Bioconjug Chem; 2007; 18(5):1415-23. PubMed ID: 17595054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the binding epitope of RGD-peptidomimetics to αvβ3 and α(IIb)β3 integrin-rich intact cells by NMR and computational studies.
    Guzzetti I; Civera M; Vasile F; Araldi EM; Belvisi L; Gennari C; Potenza D; Fanelli R; Piarulli U
    Org Biomol Chem; 2013 Jun; 11(23):3886-93. PubMed ID: 23657523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic RGD peptides interfere with binding of the Helicobacter pylori protein CagL to integrins αVβ3 and α5β1.
    Conradi J; Huber S; Gaus K; Mertink F; Royo Gracia S; Strijowski U; Backert S; Sewald N
    Amino Acids; 2012 Jul; 43(1):219-32. PubMed ID: 21915696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biochemical evaluation of a cyclic RGD oxorhenium complex as new ligand of alphaVbeta3 integrin.
    Aufort M; Gonera M; Chaignon N; Le Clainche L; Dugave C
    Eur J Med Chem; 2009 Sep; 44(9):3394-401. PubMed ID: 19303174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-angiogenesis activities of novel peptide complexes: mitochondria-disruptive 9mer peptides conjugated with the integrin alpha V beta 3-homing cyclic RGD motif.
    Iwasaki T; Yamakawa M; Asaoka A; Kawano T; Ishibashi J
    Biosci Biotechnol Biochem; 2012; 76(11):2044-8. PubMed ID: 23132564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor targeting and imaging using cyclic RGD-PEGylated gold nanoparticle probes with directly conjugated iodine-125.
    Kim YH; Jeon J; Hong SH; Rhim WK; Lee YS; Youn H; Chung JK; Lee MC; Lee DS; Kang KW; Nam JM
    Small; 2011 Jul; 7(14):2052-60. PubMed ID: 21688390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic RGD β-lactam peptidomimetics induce differential gene expression in human endothelial cells.
    Aizpurua JM; Ganboa JI; Palomo C; Loinaz I; Oyarbide J; Fernandez X; Balentová E; Fratila RM; Jiménez A; Miranda JI; Laso A; Avila S; Castrillo JL
    Chembiochem; 2011 Feb; 12(3):401-5. PubMed ID: 21290542
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of polyplex micelles installed with cyclic RGD peptide as ligand on gene delivery to vascular lesions.
    Kagaya H; Oba M; Miura Y; Koyama H; Ishii T; Shimada T; Takato T; Kataoka K; Miyata T
    Gene Ther; 2012 Jan; 19(1):61-9. PubMed ID: 21654819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET Diagnostic Molecules Utilizing Multimeric Cyclic RGD Peptide Analogs for Imaging Integrin α
    Liolios C; Sachpekidis C; Kolocouris A; Dimitrakopoulou-Strauss A; Bouziotis P
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33810198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic RGD functionalized gold nanoparticles for tumor targeting.
    Arosio D; Manzoni L; Araldi EM; Scolastico C
    Bioconjug Chem; 2011 Apr; 22(4):664-72. PubMed ID: 21434651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morpholine-based RGD-cyclopentapeptides as alphavbeta3/alphavbeta5 integrin ligands: role of configuration towards receptor binding affinity.
    Cini N; Trabocchi A; Menchi G; Bottoncetti A; Raspanti S; Pupi A; Guarna A
    Bioorg Med Chem; 2009 Feb; 17(4):1542-9. PubMed ID: 19195898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of the p38 MAPkinase inhibitor SB202190 to angiogenic endothelial cells: development of novel RGD-equipped and PEGylated drug-albumin conjugates using platinum(II)-based drug linker technology.
    Temming K; Lacombe M; van der Hoeven P; Prakash J; Gonzalo T; Dijkers EC; Orfi L; Kéri G; Poelstra K; Molema G; Kok RJ
    Bioconjug Chem; 2006; 17(5):1246-55. PubMed ID: 16984135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoscale integrin ligand patterns determine melanoma cell behavior.
    Amschler K; Erpenbeck L; Kruss S; Schön MP
    ACS Nano; 2014 Sep; 8(9):9113-25. PubMed ID: 25171587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.